Anti-thrombotic and vascular effects of AR246686, a novel 5-HT2A receptor antagonist-Reference-Cited by-同舟云学术

Anti-thrombotic and vascular effects of AR246686, a novel 5-HT2A receptor antagonist

Published:2008-05 Issue:1-3 Volume:586 Page:234-243
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Adams John W.,Ramirez Juan,Ortuno Danny,Shi Yunqing,Thomsen William,Richman Jeremy G.,Morgan Michael,Dosa Peter,Teegarden Bradley R.,Al-Shamma Hussien,Behan Dominic P.,Connolly Daniel T.

Publisher

Elsevier BV

Subject

Pharmacology

Reference33 articles.

1. Serotonin as a mediator of cyclic flow variations in stenosed canine coronary arteries;Ashton;Circulation,1986

2. Antiplatelet and antithrombotic activity of SL65.0472, a mixed 5-HT1B/5-HT2A receptor antagonist;Berry;Thromb. Haemost.,2001

3. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction;Cheng;Biochem. Pharmacol.,1973

4. The safety and efficacy of aspirin and clopidogrel as a combination treatment in patients with coronary heart disease;Cooke;Expert. Opin. Drug Saf.,2006

5. 5-hydroxytryptamine and platelet aggregation;De Clerck;Fed. Proc.,1983

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Novel Antibody Targeting the Second Extracellular Loop of the Serotonin 5-HT2A Receptor Inhibits Platelet Function;International Journal of Molecular Sciences;2022-08-08

2. Arsenic induces platelet shape change through altering focal adhesion kinase-mediated actin dynamics, contributing to increased platelet reactivity;Toxicology and Applied Pharmacology;2020-03

3. M100907 and BD 1047 attenuate the acute toxic effects of methamphetamine;NeuroToxicology;2019-09

4. Platelet Receptors;Platelets;2019

5. Anti-aggregation effect of aroxyalkyl derivatives of 2-methoxyphenylpiperazine is due to their 5-HT2A and alpha(2)-adrenoceptor antagonistic properties. A comparison with ketanserin, sarpogrelate, prazosin, yohimbine and ARC239;EUR J PHARMACOL;2018